- CEMATRIX Corporation (CVX) has announced that it has executed $4.1 million in new contracts, none of which was previously characterized as contracts in process
- The corporation’s backlog now totals $82.1 million
- The corporation’s backlog is defined as contracted plus contracts in process net of sales completed to date
- CEMATRIX manufactures and supplies technologically advanced cellular concrete products across North America
- CEMETRIX Corporation was trading at $0.24 at 9:32 AM ET, with a gain of 0.005 or 2.128 per cent
CEMATRIX Corporation (CVX) has executed $4.1 million in new contracts.
With these new contracts, converted contracts and sales completed to date, the corporation’s backlog now totals $82.1 million.
“These new contracts mainly represent new projects of various sizes all under $1 million, and all of which are scheduled to be completed in the current year,” said Jeff Kendrick, CEMATRIX President and CEO.
“As expected, bid activity for infrastructure and tunnel projects throughout North America continues to remain strong and even with recent supply chain issues, we continue to be informed by our customers that they don’t expect any further COVID delays,” he added.
The corporation’s backlog is defined as contracted plus contracts in process net of sales completed to date.
Contracts in process are defined as projects where the related contract is in office for review or signature; signed and returned to the client for their signature, or is in the post-award project submission process; or is awarded by letter of intent; or is awarded by some other form of written communication.
CEMATRIX is a cash-flow company that manufactures and supplies technologically advanced cellular concrete products developed from proprietary formulations across North America.
CEMETRIX Corporation was trading at $0.24 at 9:32 AM ET, with a gain of 0.005 or 2.128 per cent.